QNRX — Quoin Pharmaceuticals, Ltd. American Depositary Shares
XNAS · Healthcare · Biotechnology
Price$6.12
Market Cap$12.3M
P/E—
52W Range$3.25 – $41.80
Next Earnings2026-11-05
About Quoin Pharmaceuticals, Ltd. American Depositary Shares
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.